Recruiting NA Relapse

New treatment option for Relapse

Official title ''Comparative Evaluation of Change in Bite Force and Levels of Bone Turnover Markers CTX and BALP in Hyperdivergent and Hypodivergent Cases During Retention Phases-A Prospective Clinical Trial ''

ClinicalTrials.gov ID: NCT06456827

What this study is testing

What it's testing
Long-term studies have shown that various occlusal changes occur after the active phase of orthodontic treatment. some of these changes are unwanted changes and are considered as relapse The retention appliances are used to maintain the arch dimensions and alignment of the teeth after completion of the orthodontic treatment.
  • Time commitment: about 12 months
  • This is a blinded study.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45. Healthy volunteers may be eligible.

You may be able to join if

  • Non - growing (18-25) patients who had finished Fixed orthodontic cases ( ready for debonding )with FMA of 26 or more for hyperdivergent cases and...
  • Optimal functional occlusion at end of treatment (PAR score \>70%).
  • Littles irregularity index (Pre-treatment \<6mm in both upper and lower arch).
  • Nonsurgical and non-orthopedic patients and non syndromic patients.
  • Optimal periodontal condition and Good oral hygiene (probing depth \<3mm, gingival index score \<1

You likely can't join if

  • people with incomplete orthodontic treatment.
  • TMJ disorder patients.
  • Any systemic disease affecting bone and general growth.
  • Patients with incomplete records.
  • Patient who fail to follow up or undergo complete treatment.
  • Patient with learning difficulties
See the full eligibility criteria
Who can join
  • Non - growing (18-25) patients who had finished Fixed orthodontic cases ( ready for debonding )with FMA of 26 or more for hyperdivergent cases and FMA of 24 or less for hypodivergent cases
  • Optimal functional occlusion at end of treatment (PAR score \>70%).
  • Littles irregularity index (Pre-treatment \<6mm in both upper and lower arch).
  • Nonsurgical and non-orthopedic patients and non syndromic patients.
  • Optimal periodontal condition and Good oral hygiene (probing depth \<3mm, gingival index score \<1
  • Good compliance regarding retainer wear
What rules you out
  • people with incomplete orthodontic treatment.
  • TMJ disorder patients.
  • Any systemic disease affecting bone and general growth.
  • Patients with incomplete records.
  • Patient who fail to follow up or undergo complete treatment.
  • Patient with learning difficulties
  • Patients having antibiotic therapy within previous 3 months and used anti -inflammatory drugs in the month before the study

The study team makes the final eligibility decision.

Where it's taking place

  • Rohtak, Haryana, India

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 45 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Rohtak, Haryana, India. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.